AstraZeneca Free Cash Flow Per Share from 2010 to 2024
| AZN Stock | USD 78.99 0.97 1.24% |
Free Cash Flow Per Share | First Reported 2010-12-31 | Previous Quarter 2.11975468 | Current Value 2.23 | Quarterly Volatility 0.84031713 |
Check AstraZeneca PLC financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AstraZeneca PLC's main balance sheet or income statement drivers, such as Depreciation And Amortization of 5.2 B, Interest Expense of 1.7 B or Total Revenue of 24.2 B, as well as many indicators such as Price To Sales Ratio of 2.62, Dividend Yield of 0.0285 or PTB Ratio of 9.53. AstraZeneca financial statements analysis is a perfect complement when working with AstraZeneca PLC Valuation or Volatility modules.
AstraZeneca | Free Cash Flow Per Share |
Latest AstraZeneca PLC's Free Cash Flow Per Share Growth Pattern
Below is the plot of the Free Cash Flow Per Share of AstraZeneca PLC ADR over the last few years. It is the amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share. AstraZeneca PLC's Free Cash Flow Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AstraZeneca PLC's overall financial position and show how it may be relating to other accounts over time.
| Free Cash Flow Per Share | 10 Years Trend |
|
Free Cash Flow Per Share |
| Timeline |
AstraZeneca Free Cash Flow Per Share Regression Statistics
| Arithmetic Mean | 1.24 | |
| Geometric Mean | 0.90 | |
| Coefficient Of Variation | 67.80 | |
| Mean Deviation | 0.74 | |
| Median | 0.92 | |
| Standard Deviation | 0.84 | |
| Sample Variance | 0.71 | |
| Range | 2.211 | |
| R-Value | 0.26 | |
| Mean Square Error | 0.71 | |
| R-Squared | 0.07 | |
| Significance | 0.35 | |
| Slope | 0.05 | |
| Total Sum of Squares | 9.89 |
AstraZeneca Free Cash Flow Per Share History
About AstraZeneca PLC Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include AstraZeneca PLC income statement, its balance sheet, and the statement of cash flows. AstraZeneca PLC investors use historical funamental indicators, such as AstraZeneca PLC's Free Cash Flow Per Share, to determine how well the company is positioned to perform in the future. Although AstraZeneca PLC investors may use each financial statement separately, they are all related. The changes in AstraZeneca PLC's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on AstraZeneca PLC's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on AstraZeneca PLC Financial Statements. Understanding these patterns can help to make the right decision on long term investment in AstraZeneca PLC. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Free Cash Flow Per Share | 2.12 | 2.23 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Information and Resources on Investing in AstraZeneca Stock
When determining whether AstraZeneca PLC ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AstraZeneca PLC's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrazeneca Plc Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrazeneca Plc Adr Stock:Check out the analysis of AstraZeneca PLC Correlation against competitors. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AstraZeneca PLC. If investors know AstraZeneca will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AstraZeneca PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.207 | Dividend Share 2.9 | Earnings Share 2.03 | Revenue Per Share 2.5512 | Quarterly Revenue Growth 0.165 |
The market value of AstraZeneca PLC ADR is measured differently than its book value, which is the value of AstraZeneca that is recorded on the company's balance sheet. Investors also form their own opinion of AstraZeneca PLC's value that differs from its market value or its book value, called intrinsic value, which is AstraZeneca PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AstraZeneca PLC's market value can be influenced by many factors that don't directly affect AstraZeneca PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AstraZeneca PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if AstraZeneca PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AstraZeneca PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.